Articles
6924 result(s) for 'sepsis' within Critical Care
Page 1 of 139
-
Citation: Critical Care 2000 4(Suppl 1):P71
-
Impact of the sepsis bundle strategy on the outcomes of the patients suffering from severe sepsis and septic shock
Citation: Critical Care 2010 14(Suppl 1):P400 -
Usefulness of sepsis screening tools and education in recognising the burden of sepsis on hospital wards
Citation: Critical Care 2015 19(Suppl 1):P3 -
Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)
Citation: Critical Care 2011 15(Suppl 1):P268 -
Toll-like receptor pathway signaling is differently regulated in neurophils and peripheral mononuclear cells of patients with sepsis, severe sepsis and septic shock
Citation: Critical Care 2008 12(Suppl 5):P45 -
Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
Citation: Critical Care 2000 3(Suppl 1):P095 -
Costs of severe sepsis according to the guidelines of the 'Surviving Sepsis Campaign'
Citation: Critical Care 2005 9(Suppl 1):P198 -
Effects of PPARγ in dendritic cells during severe sepsis and sepsis-induced immunosuppression
Citation: Critical Care 2013 17(Suppl 4):P101 -
Compliance with the sepsis resuscitation bundle in patients with severe sepsis and septic shock admitted to Scottish ICUs
Citation: Critical Care 2012 16(Suppl 1):P54 -
ICU mortality rates in patients with sepsis before and after the Surviving Sepsis Campaign
Citation: Critical Care 2015 19(Suppl 1):P15 -
The impact of protocolized sepsis order set on the process of care in patients with severe sepsis/septic shock
Citation: Critical Care 2007 11(Suppl 4):P6 -
Sepsis: a study of physician's knowledge about the Surviving Sepsis Campaign in Puerto Rico
Citation: Critical Care 2006 10(Suppl 1):P126 -
Relation between mixed venous and central venous saturation in sepsis: influence of source of sepsis
Citation: Critical Care 2009 13(Suppl 1):P227 -
Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
Citation: Critical Care 2005 9(Suppl 1):P332 -
The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models
Citation: Critical Care 2010 14(Suppl 2):P19 -
An epidemiological study of sepsis in ICUs: Sepsis Brazil Study
Citation: Critical Care 2006 10(Suppl 1):P111 -
Effects on outcome of patients with severe sepsis and septic shock admitted to the ICU after implementation cooperative sepsis management protocol
Citation: Critical Care 2012 16(Suppl 3):P104 -
Evaluation of procalcitonin as a diagnostic and prognostic marker in patients with sepsis, severe sepsis and septic shock associated with ventilator-associated pneumonia
Citation: Critical Care 2005 9(Suppl 1):P164 -
ICU mortality rates in patients with sepsis compared with patients without sepsis
Citation: Critical Care 2015 19(Suppl 1):P14 -
Employing quality improvement methodology in sepsis: an electronic sepsis order set further improves compliance with the Surviving Sepsis Campaign 3-hour bundle
Citation: Critical Care 2014 18(Suppl 1):P363 -
Different correlations between lymphocyte subsets from patients with intra-abdominal sepsis and pneumonia-derived sepsis
Citation: Critical Care 2011 15(Suppl 1):P260 -
Association between sex and mortality in patients with sepsis admitted to the ICU: gender and sex hormones influence the response to sepsis?
Citation: Critical Care 2009 13(Suppl 3):P19 -
CD64 upregulation on peripheral granulocytes is not a marker of sepsis and does not correlate with serum concentrations of granulocyte colony-stimulating factor (G-CSF) in postoperative/posttraumatic patients with severe sepsis
Citation: Critical Care 1998 2(Suppl 1):P013 -
The Cost of Albumin Sepsis Treatment (COAST) study: efficacy analysis of albumin for severe sepsis. Modelling using the SAFE study and CUB-Rea data
Citation: Critical Care 2006 10(Suppl 1):P177 -
C-reactive protein as an early marker of sepsis resolution: results from the Portuguese Community-acquired Sepsis Study (SACiUCI study)
Citation: Critical Care 2011 15(Suppl 1):P272 -
Impact of the Surviving Sepsis Campaign implementation on severe sepsis outcome
Citation: Critical Care 2011 15(Suppl 2):P14 -
Hemodialysis with high cutoff membranes improves tissue perfusion in severe sepsis: preliminary data of the Sepsis in Florence sTudy (SIFT)
Citation: Critical Care 2014 18(Suppl 1):P401 -
Prognostic factors of severe sepsis: a result of Korean sepsis registry system
Citation: Critical Care 2008 12(Suppl 5):P42 -
Surviving sepsis campaign guidelines for severe sepsis and septic shock: implementation and outcome of a 3-year follow up
Citation: Critical Care 2009 13(Suppl 1):P340 -
Innate immunity and inflammation in sepsis: mechanisms by which acute ethanol exposure alters the course of sepsis and the effect to TLR4 signaling
Citation: Critical Care 2010 14(Suppl 2):P17 -
Erratum to: Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study
Citation: Critical Care 2005 9:169 -
Femoral central lines and clinical sepsis
Citation: Critical Care 2003 7(Suppl 2):P118 -
Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome in patients with systemic inflammatory response syndrome
Citation: Critical Care 2004 8(Suppl 1):P196 -
C1-esterase inhibitor (C1INH) implication in systemic inflammation in sepsis
Citation: Critical Care 2010 14(Suppl 1):P28 -
Prevalence of vitamin D deficiency among children with sepsis, its association with sepsis severity and its outcome in a pediatric ICU
Citation: Critical Care 2013 17(Suppl 4):P35 -
The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
Great advances have been made in describing the intracellular pathways and genes that are activated by bacterial products. New definitions and therapies for sepsis will be based on such cellular and genetic alter...
Citation: Critical Care 2002 6:277 -
A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression
Citation: Critical Care 2011 15(Suppl 3):P37 -
AZD9773, a novel anti-TNFα immune Fab in development for severe sepsis and septic shock: demonstration of safety and efficacy in a murine CLP sepsis model
Citation: Critical Care 2011 15(Suppl 3):P41 -
Compared values of presepsin (sCD14-ST) and procalcitonin as early markers of outcome in severe sepsis and septic shock: a preliminary report from the Albumin Italian Outcome Sepsis (ALBIOS) study
Citation: Critical Care 2013 17(Suppl 2):P35 -
Mortality reduction in patients with severe sepsis and septic shock through a comprehensive sepsis initiative
Citation: Critical Care 2014 18(Suppl 2):P28 -
Impact of an educational program on the Surviving Sepsis Campaign implementation for sepsis management
Citation: Critical Care 2008 12(Suppl 5):P11 -
Impact of the Surviving Sepsis Campaign clinical guideline of in sepsis mortality in a public health institution in Brazil
Citation: Critical Care 2013 17(Suppl 4):P4 -
Sepsis electronic surveillance and clinical outcomes: impact over mortality of a sepsis early detection electronic rule implemented in the emergency department
Citation: Critical Care 2014 18(Suppl 2):P21 -
Similarity of inflammatory response in epileptic seizures and sepsis: does the sensitivity to sepsis in epileptic patients increase?
Citation: Critical Care 2014 18(Suppl 2):P56 -
The Surviving Sepsis Campaign sepsis change bundles and clinical practice
The Surviving Sepsis Campaign (SSC) is an international effort to reduce mortality in severe sepsis and septic shock. The campaign included the ... by 11 international organizations. From these guidelines, sepsis
Citation: Critical Care 2005 9:653 -
Quality assurance in severe sepsis: an individualised audit/feedback system results in substantial improvements in sepsis care at a large UK teaching hospital
Citation: Critical Care 2013 17(Suppl 4):P61 -
Increasing awareness of sepsis: World Sepsis Day
Citation: Critical Care 2012 16:152 -
Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury
The triggering receptor expressed on myeloid cells-1 (TREM-1) is an immunoreceptor whose role is to amplify the inflammatory response mediated by the engagement of Toll-like and NOD-like receptors. As the express...
Citation: Critical Care 2011 15:1013 -
Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis
Citation: Critical Care 2013 17:419 -
The effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in patients with sepsis
Citation: Critical Care 2005 9(Suppl 1):P363
Follow
- ISSN: 1364-8535 (electronic)